Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - TOTAL CURRENT ASSETS
Total Current Assets AKBA - Akebia Therapeutics, Inc.
118 M
LAST VALUE
-34.09%
2 YEAR CAGR
-24.07%
5 YEAR CAGR
13.46%
10 YEAR CAGR